Florian Reinaud, Board member

  • 2010

    8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...

    Read More >

  • Meet us

    The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...

    Read More >

Florian Reinaud, Board member

 

Board member since 2009. Florian Reinaud holds a medical degree from Imperial College London and a BA(hons) in Physiology from Oxford University. 

Before joining CDC, Florian Reinaud was the CFO of Paris-based DBV Technologies. Prior to that, he worked at Apax Partners in Paris. As part of the healthcare team, he invested across all stages of company maturity, from start-ups in the biotech and medtech fields, to growth capital and large buy-outs in the healthcare services field.

Previously Florian was an equity analyst at Schroder Salomon Smith Barney (Citigroup) covering the pan-European medtech and healthcare servicessectors. Prior to that he was a doctor working in the UK’s National Health Service (Accident & Emergency and Internal Medicine). 

 

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.